Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular

Vincent Plagnol1, Samuel Woodhouse1, Karen Howarth1

  • 1Research and Development, Inivata Ltd, Granta Park, Cambridge, United Kingdom.

Plos One
|March 16, 2018
PubMed

Insights

The InVisionFirst assay accurately detects low-frequency mutations in circulating tumor DNA (ctDNA) for cancer care. This highly sensitive and specific assay is validated for clinical use in profiling patients and guiding treatment decisions.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Diagnostics

Background:

  • Circulating tumor DNA (ctDNA) analysis is crucial for cancer patient profiling and guiding targeted therapy decisions.
  • Detecting low-frequency mutations (below 0.5% VAF) in ctDNA requires highly sensitive analytical methods for clinical utility.
  • Objective assessment of assay performance necessitates rigorous analytical validation.

Purpose of the Study:

  • To develop and analytically validate the InVisionFirst™ assay for profiling actionable genomic alterations in cell-free DNA.
  • To assess the assay's sensitivity, specificity, and robustness in detecting various mutation types across a range of variant allele fractions (VAFs).
  • To confirm the assay's suitability for clinical applications in cancer care.

Main Methods:

  • Development of the InVisionFirst™ assay utilizing enhanced tagged amplicon sequencing (eTAm-Seq™) technology.
  • Profiling of 36 cancer-associated genes for point mutations, indels, amplifications, and gene fusions in cell-free DNA.
  • Analytical validation using patient samples (non-small cell lung cancer patients and healthy donors) and contrived samples with known VAFs, compared against digital PCR (dPCR).

Main Results:

  • The InVisionFirst assay demonstrated high sensitivity: 99.48% for SNVs at 0.25%-0.33% VAF and 92.46% for indels at 0.25% VAF.
  • Exceptional specificity (99.9997% per base) was maintained, with high detection rates at low VAFs.
  • The assay successfully detected gene fusions (ALK, ROS1) and amplifications (ERBB2, FGFR1, MET, EGFR) with high sensitivity and specificity, showing strong concordance with dPCR.

Conclusions:

  • The InVisionFirst assay is a highly sensitive, specific, and robust method for detecting actionable genomic alterations in ctDNA.
  • The assay meets the analytical requirements for clinical applications, supporting its use in cancer patient profiling and treatment guidance.
  • This validated assay enables reliable detection of low-frequency mutations, advancing precision oncology.

Related Concept Videos

Molecular Comparison of Gases, Liquids, and Solids02:26

Molecular Comparison of Gases, Liquids, and Solids

Particles in a solid are tightly packed together (fixed shape) and often arranged in a regular pattern; in a liquid, they are close together with no regular arrangement (no fixed shape); in a gas, they are far apart with no regular arrangement (no fixed shape). Particles in a solid vibrate about fixed positions (cannot flow) and do not generally move in relation to one another; in a liquid, they move past each other (can flow) but remain in essentially constant contact; in a gas, they move...
55.6K
Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
98.8K
Reliability and Validity01:29

Reliability and Validity

Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
14.1K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.9K
Development of Analytical Methods01:21

Development of Analytical Methods

An analytical methodology can be divided into four sequential steps: technique, method, procedure, and protocol. A technique is a scientific principle that rationalizes a specific phenomenon through chemical measurements. Adapting a technique for analyzing a sample of interest is termed a method. The procedure outlines the directions for performing the analysis via an analytical method. The protocol is the detailed guidelines on the procedure, which should be strictly followed to obtain the...
2.3K
Data Validation01:15

Data Validation

Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
2.2K